186 related articles for article (PubMed ID: 27609654)
1. Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.
Jabara HH; Lee JJ; Janssen E; Ullas S; Liadaki K; Garibyan L; Benson H; Sannikova T; Bram R; Hammarstrom L; Cruz AC; Siegel R; Manis J; Malley R; Geha RS
J Allergy Clin Immunol; 2017 Apr; 139(4):1293-1301.e4. PubMed ID: 27609654
[TBL] [Abstract][Full Text] [Related]
2. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.
Lee JJ; Rauter I; Garibyan L; Ozcan E; Sannikova T; Dillon SR; Cruz AC; Siegel RM; Bram R; Jabara H; Geha RS
Blood; 2009 Sep; 114(11):2254-62. PubMed ID: 19605846
[TBL] [Abstract][Full Text] [Related]
3. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.
Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB
J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042
[TBL] [Abstract][Full Text] [Related]
4. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
6. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
Banday VS; Thyagarajan R; Sundström M; Lejon K
Immunology; 2016 Nov; 149(3):297-305. PubMed ID: 27444337
[TBL] [Abstract][Full Text] [Related]
8. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation.
Castigli E; Wilson SA; Elkhal A; Ozcan E; Garibyan L; Geha RS
J Allergy Clin Immunol; 2007 Oct; 120(4):885-91. PubMed ID: 17689597
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndrome.
Chinen J; Martinez-Gallo M; Gu W; Cols M; Cerutti A; Radigan L; Zhang L; Potocki L; Withers M; Lupski JR; Cunningham-Rundles C
J Allergy Clin Immunol; 2011 Jun; 127(6):1579-86. PubMed ID: 21514638
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiency.
Dong X; Hoeltzle MV; Hagan JB; Park MA; Li JT; Abraham RS
Hum Immunol; 2010 May; 71(5):505-11. PubMed ID: 20156508
[TBL] [Abstract][Full Text] [Related]
12. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
[TBL] [Abstract][Full Text] [Related]
13. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).
Garibyan L; Lobito AA; Siegel RM; Call ME; Wucherpfennig KW; Geha RS
J Clin Invest; 2007 Jun; 117(6):1550-7. PubMed ID: 17492055
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.
Zhang L; Radigan L; Salzer U; Behrens TW; Grimbacher B; Diaz G; Bussel J; Cunningham-Rundles C
J Allergy Clin Immunol; 2007 Nov; 120(5):1178-85. PubMed ID: 17983875
[TBL] [Abstract][Full Text] [Related]
15. Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice.
Uslu K; Coleman AS; Allman WR; Katsenelson N; Bram RJ; Alugupalli KR; Akkoyunlu M
J Immunol; 2014 Apr; 192(8):3582-95. PubMed ID: 24646744
[TBL] [Abstract][Full Text] [Related]
16. TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens.
Mantchev GT; Cortesão CS; Rebrovich M; Cascalho M; Bram RJ
J Immunol; 2007 Aug; 179(4):2282-8. PubMed ID: 17675489
[TBL] [Abstract][Full Text] [Related]
17. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival.
Ou X; Xu S; Lam KP
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15401-6. PubMed ID: 22949644
[TBL] [Abstract][Full Text] [Related]
18. Common variable immunodeficiency: two mutations are better than one.
La Cava A
J Clin Invest; 2013 Oct; 123(10):4142-3. PubMed ID: 24051372
[TBL] [Abstract][Full Text] [Related]
19. TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.
Allman WR; Dey R; Liu L; Siddiqui S; Coleman AS; Bhattacharya P; Yano M; Uslu K; Takeda K; Nakhasi HL; Akkoyunlu M
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4094-103. PubMed ID: 26170307
[TBL] [Abstract][Full Text] [Related]
20. Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells.
Smulski CR; Zhang L; Burek M; Teixidó Rubio A; Briem JS; Sica MP; Sevdali E; Vigolo M; Willen L; Odermatt P; Istanbullu D; Herr S; Cavallari M; Hess H; Rizzi M; Eibel H; Schneider P
Cell Rep; 2022 Mar; 38(13):110583. PubMed ID: 35354034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
